Specific Sialoforms Required for the Immune Suppressive Activity of Human Soluble CD52-Reference-Cited by-同舟云学术

Specific Sialoforms Required for the Immune Suppressive Activity of Human Soluble CD52

Published:2019-08-27 Issue: Volume:10 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Shathili Abdulrahman M.,Bandala-Sanchez Esther,John Alan,Goddard-Borger Ethan D.,Thaysen-Andersen Morten,Everest-Dass Arun V.,Adams Timothy E.,Harrison Leonard C.,Packer Nicolle H.

Funder

National Health and Medical Research Council

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference27 articles.

1. Characterization of the CAMPATH-1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone;Xia;Eur J Immunol.,1991

2. Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis;Xia;Biochem J.,1993

3. T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10;Bandala-Sanchez;Nat Immunol.,2013

4. CD52 glycan binds the proinflammatory B box of HMGB1 to engage the Siglec-10 receptor and suppress human T cell function;Bandala-Sanchez;Proc Natl Acad Sci USA.,2018

5. CD52 inhibits Toll-like receptor activation of NF-κB and triggers apoptosis to suppress inflammation;Rashidi;Cell Death Differ.,2018

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the CD24-Siglec10 Axis: A Potential Strategy for Cancer Immunotherapy;BIO Integration;2024

2. Glycosyltransferases as versatile tools to study the biology of glycans;Glycobiology;2023-11-13

3. Siglec10—An immunosuppressor and negative predictor of survival prognosis in gliomas;Frontiers in Genetics;2022-11-16

4. Sialic acid and food allergies: The link between nutrition and immunology;Critical Reviews in Food Science and Nutrition;2022-11-12

5. Improvement of Lipoplexes With a Sialic Acid Mimetic to Target the C1858T PTPN22 Variant for Immunotherapy in Endocrine Autoimmunity;Frontiers in Immunology;2022-03-09